Compared with ordinary paclitaxel, liposomal paclitaxel is the paclitaxel drug included inside the lipid, which causes mild adverse reactions and the efficacy of the drug is increased. Paclitaxel is one of the commonly used antitumor chemotherapeutic drugs, which has good efficacy in malignant tumors such as breast cancer, head and neck malignant tumors, esophageal cancer, and lymphoma. Liposomal Paclitaxel is wrapped the Paclitaxel drug with lipid, which enhances the water solubility of the drug and improves the solubility of the drug. It can be in the enhancement of the effect of the drug and reduce the adverse effects of paclitaxel. However, liposomal paclitaxel also has shortcomings, such as poor selectivity for cancer cells, poor tissue and organ specificity and other characteristics. In addition to liposomal paclitaxel, there is also albumin-bound paclitaxel, which has higher selectivity relative to the original drug. The use of paclitaxel and its derivatives must be under the supervision of an oncologist.